Medtronic's Melody Transcatheter Pulmonary Valve Gets FDA Panel Date
This article was originally published in The Gray Sheet
Executive Summary
FDA's Circulatory System Devices Panel will review a humanitarian device exemption application for Medtronic's Melody transcatheter pulmonary valve and Ensemble delivery system July 22, according to a July 2 Federal Register notice
You may also be interested in...
Medtronic Catapults Into Transcatheter Valve Market With Billion-Dollar Buys
Medtronic will enter the high-growth, minimally invasive aortic heart valve market through two acquisitions worth more than $1 billion
Medtronic Melody Data Sings; Transcatheter Heart Valve Awaits HDE
Feasibility trial results show Medtronic's Melody transcatheter pulmonary heart valve reduces right ventricular volume by 18% in patients with dysfunctional right ventricular outflow tract conduits
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.